Ah receptor and NF-κB interplay on the stage of epigenome

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 670-680

  Tian, Yanan ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Ah receptor; Dioxin; Epigenetics; Inflammation; NF B

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; DIOXIN; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA POLYMERASE II;

ACETYLATION; CHROMATIN STRUCTURE; DETOXIFICATION; ENZYME PHOSPHORYLATION; EPIGENETICS; GENE EXPRESSION REGULATION; GENE REPRESSION; GENOTOXICITY; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; XENOBIOTIC METABOLISM;

ANIMALS; CHROMATIN; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; RECEPTOR CROSS-TALK; RECEPTORS, ARYL HYDROCARBON;

EID: 59349114674     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.10.023     Document Type: Review

References (92)

1. Ettmayer P., Mayer P., Kalthoff F., Neruda W., Harrer N., Hartmann G., et al. A novel low molecular weight inhibitor of dendritic cells and B cells blocks allergic inflammation. Am J Respir Crit Care Med 173 (2006) 599-606
2. Hauben E., Gregori S., Draghici E., Migliavacca B., Olivieri S., Woisetschlager M., et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 112 (2008) 1214-1222
3. Lawrence B.P., Denison M.S., Novak H., Vorderstrasse B.A., Harrer N., Neruda W., et al. Activation of the aryl hydrocarbon receptor is essential for mediating the anti-inflammatory effects of a novel low-molecular-weight compound. Blood 112 (2008) 1158-1165
4. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., et al. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268 (1995) 722-726
5. Hankinson O. The role of the aryl hydrocarbon receptor nuclear translocator protein in aryl hydrocarbon receptor action. Trends Endocrinol Metabol 5 (1994) 240-244
6. Okey A.B. An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture International Congress of Toxicology-XI. Toxicol Sci 98 (2007) 5-38
7. Hayden M.S., and Ghosh S. Shared principles in NF-kappaB signaling. Cell 132 (2008) 344-362
8. Karin M. The IkappaB kinase - a bridge between inflammation and cancer. Cell Res 18 (2008) 334-342
9. Rius J., Guma M., Schachtrup C., Akassoglou K., Zinkernagel A.S., Nizet V., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453 (2008) 807-811
10. Tian Y., Ke S., Denison M.S., Rabson A.B., and Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J Biol Chem 274 (1999) 510-515
11. Vogel C.F., Sciullo E., Li W., Wong P., Lazennec G., and Matsumura F. RelB a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 21 (2007) 2941-2955
12. Sulentic C.E., Holsapple M.P., and Kaminski N.E. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J Pharmacol Exper Ther 295 (2000) 705-716
13. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., et al. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Pharmacol 59 (2000) 997-1005
14. Poland A., Glover E., and Kende A.S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J Biol Chem 251 (1976) 4936-4946
15. Ema M., Sogawa K., Watanabe N., Chujoh Y., Matsushita N., Gotoh O., et al. cDNA cloning and structure of mouse putative Ah receptor. Biochem Biophys Res Commun 184 (1992) 246-253
16. Burbach K.M., Poland A., and Bradfield C.A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 89 (1992) 8185-8189
17. Gu Y.Z., Hogenesch J.B., and Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40 (2000) 519-561
18. Safe S., and Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 16 (2003) 807-816
19. Denis M., Wilhelmsson A., Cuthill S., Poellinger L., and Gustafsson J.A. Structural differences between the glucocorticoid, dioxin and oxysterol receptors from rat liver cytosol. Biochem Biophys Res Commun 163 (1989) 444-451
20. Perdew G.H. Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem 263 (1988) 13802-13805
21. Swanson H.I., Chan W.K., and Bradfield C.A. DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins. J Biol Chem 270 (1995) 26292-26302
22. Reyes H., Reisz-Porszasz S., and Hankinson O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256 (1992) 1193-1195
23. Oesch-Bartlomowicz B., Huelster A., Wiss O., Antoniou-Lipfert P., Dietrich C., Arand M., et al. Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways. Proc Natl Acad Sci USA 102 (2005) 9218-9223
24. Whitlock Jr. J.P. Induction of cytochrome P4501A1. Annu Rev Pharmacol Toxicol 39 (1999) 103-125
25. Fujii-Kuriyama Y., and Mimura J. Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes. Biochem Biophys Res Commun 338 (2005) 311-317
26. Sen R., and Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46 (1986) 705-716
27. Bonizzi G., Bebien M., Otero D.C., Johnson-Vroom K.E., Cao Y., Vu D., et al. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers. EMBO J 23 (2004) 4202-4210
28. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immun 25 (2004) 280-288
29. Barouki R., Coumoul X., and Fernandez-Salguero P.M. The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581 (2007) 3608-3615
30. Morgan E.T., Goralski K.B., Piquette-Miller M., Renton K.W., Robertson G.R., Chaluvadi M.R., et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos: the biological fate of chemicals 36 (2008) 205-216
31. Tian Y., Rabson A.B., and Gallo M.A. Ah receptor and NF-kappaB interactions: mechanisms and physiological implications. Chemico-Biol Interact 141 (2002) 97-115
32. Zhang Y., Broser M., and Rom W.N. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci USA 91 (1994) 2225-2229
33. Mendez-Samperio P., Palma J., and Vazquez A. Roles of intracellular calcium and NF-kappaB in the Bacillus Calmette-Guerin-induced secretion of interleukin-8 from human monocytes. Cellular Immun 211 (2001) 113-122
34. Sharova L., Sura P., Smith B.J., Gogal Jr. R.M., Sharov A.A., Ward D.L., et al. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus. Teratology 62 (2000) 420-428
35. Holladay S.D., Sharova L.V., Punareewattana K., Hrubec T.C., Gogal Jr. R.M., Prater M.R., et al. Maternal immune stimulation in mice decreases fetal malformations caused by teratogens. Int Immunopharmacol 2 (2002) 325-332
36. Abbott B.D., Perdew G.H., Buckalew A.R., and Birnbaum L.S. Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol Appl Pharm 128 (1994) 138-150
37. Abbott B.D. Review of the interaction between TCDD and glucocorticoids in embryonic palate. Toxicology 105 (1995) 365-373
38. Thatcher T.H., Maggirwar S.B., Baglole C.J., Lakatos H.F., Gasiewicz T.A., Phipps R.P., et al. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol 170 (2007) 855-864
39. Yu Z., Loehr C.V., Fischer K.A., Louderback M.A., Krueger S.K., Dashwood R.H., et al. In utero exposure of mice to dibenzo[a,l]pyrene produces lymphoma in the offspring: role of the aryl hydrocarbon receptor. Cancer Res 66 (2006) 755-762
40. Uno S., Dalton T.P., Dragin N., Curran C.P., Derkenne S., Miller M.L., et al. Oral benzo[a]pyrene in Cyp1 knockout mouse lines: CYP1A1 important in detoxication, CYP1B1 metabolism required for immune damage independent of total-body burden and clearance rate. Mol Pharm 69 (2006) 1103-1114
41. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 (2006) 431-436
42. Ge N.L., and Elferink C.J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein, linking dioxin signaling to the cell cycle. J Biol Chem 273 (1998) 22708-22713
43. Kolluri S.K., Weiss C., Koff A., and Gottlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 13 (1999) 1742-1753
44. Puga A., Barnes S.J., Dalton T.P., Chang C., Knudsen E.S., and Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J Biol Chem 275 (2000) 2943-2950
45. Marlowe J.L., Knudsen E.S., Schwemberger S., and Puga A. The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression. J Biol Chem 279 (2004) 29013-29022
46. Olnes M.J., Verma M., and Kurl R.N. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated gene expression in the immature rat thymus. Exper Clin Immuno 11 (1994) 102-109
47. Olnes M.J., Verma M., and Kurl R.N. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates expression of the prostaglandin G/H synthase-2 gene in rat thymocytes. J Pharmacol Exper Ther 279 (1996) 1566-1573
48. Wang Z., and Tai H.H. Interleukin-1 beta and dexamethasone regulate gene expression of prostaglandin H synthase-2 via the NF-kB pathway in human amnion derived WISH cells. Prostaglandins Leukot Essent Fatty Acids 59 (1998) 63-69
49. Sulentic C.E., Holsapple M.P., and Kaminski N.E. Aryl hydrocarbon receptor-dependent suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol 53 (1998) 623-629
50. Hollingshead B.D., Beischlag T.V., Dinatale B.C., Ramadoss P., and Perdew G.H. Inflammatory signaling and aryl hydrocarbon receptor mediate synergistic induction of interleukin 6 in MCF-7 cells. Cancer Res 68 (2008) 3609-3617
51. Kim D.W., Gazourian L., Quadri S.A., Romieu-Mourez R., Sherr D.H., and Sonenshein G.E. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19 (2000) 5498-5506
52. Camacho I.A., Singh N., Hegde V.L., Nagarkatti M., and Nagarkatti P.S. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J Immunol 175 (2005) 90-103
53. Vogel C.F., Sciullo E., and Matsumura F. Involvement of RelB in aryl hydrocarbon receptor-mediated induction of chemokines. Biochem Biophys Res Commun 363 (2007) 722-726
54. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453 (2008) 65-71
55. Bergander L., Wahlstrom N., Alsberg T., Bergman J., Rannug A., and Rannug U. Characterization of in vitro metabolites of the aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole by liquid chromatography-mass spectrometry and NMR. Drug Metab Dispos: the biological fate of chemicals 31 (2003) 233-241
56. Hilliard B., Samoilova E.B., Liu T.S., Rostami A., and Chen Y. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice: roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol 163 (1999) 2937-2943
57. Kouzarides T. Chromatin modifications and their function. Cell 128 (2007) 693-705
58. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
59. Bernstein B.E., Meissner A., and Lander E.S. The mammalian epigenome. Cell 128 (2007) 669-681
60. Li B., Carey M., and Workman J.L. The role of chromatin during transcription. Cell 128 (2007) 707-719
61. Ke S., Rabson A.B., Germino J.F., Gallo M.A., and Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J Biol Chem 276 (2001) 39638-39644
62. Tian Y., Ke S., Chen M., and Sheng T. Interactions between the aryl hydrocarbon receptor and P-TEFb, Sequential recruitment of transcription factors and differential phosphorylation of C-terminal domain of RNA polymerase II at cyp1a1 promoter. J Biol Chem 278 (2003) 44041-44048
63. Beischlag T.V., Wang S., Rose D.W., Torchia J., Reisz-Porszasz S., Muhammad K., et al. Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex. Mol Cell Biol 22 (2002) 4319-4333
64. Wang F., Zhang R., Beischlag T.V., Muchardt C., Yaniv M., and Hankinson O. Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. J Biol Chem 279 (2004) 46733-46741
65. Beischlag T.V., Taylor R.T., Rose D.W., Yoon D., Chen Y., Lee W.H., et al. Recruitment of thyroid hormone receptor/retinoblastoma-interacting protein 230 by the aryl hydrocarbon receptor nuclear translocator is required for the transcriptional response to both dioxin and hypoxia. J Biol Chem 279 (2004) 54620-54628
66. Riddick D.S., Lee C., Bhathena A., Timsit Y.E., Cheng P.Y., Morgan E.T., et al. Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab Dispos: the biological fate of chemicals 32 (2004) 367-375
67. Barouki R., and Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol 61 (2001) 511-516
68. Chan W.K., Yao G., Gu Y.Z., and Bradfield C.A. Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways, Demonstration of competition and compensation. J Biol Chem 274 (1999) 12115-12123
69. Kumar M.B., Tarpey R.W., and Perdew G.H. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J Biol Chem 274 (1999) 22155-22164
70. Chen Y.H., Beischlag T.V., Kim J.H., Perdew G.H., and Stallcup M.R. Role of GAC63 in transcriptional activation mediated by the aryl hydrocarbon receptor. J Biol Chem 281 (2006) 12242-12247
71. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85 (1996) 403-414
72. Sheppard K.A., Phelps K.M., Williams A.J., Thanos D., Glass C.K., Rosenfeld M.G., et al. Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 273 (1998) 29291-29294
73. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., et al. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19 (1999) 6367-6378
74. Chen D., Ma H., Hong H., Koh S.S., Huang S.M., Schurter B.T., et al. Regulation of transcription by a protein methyltransferase. Science 284 (1999) 2174-2177
75. Koh S.S., Li H., Lee Y.H., Widelitz R.B., Chuong C.M., and Stallcup M.R. Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators. J Biol Chem 277 (2002) 26031-26035
76. Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., and Zhu Y.J. Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J Biol Chem 277 (2002) 28624-28630
77. Rizzo G., Renga B., Antonelli E., Passeri D., Pellicciari R., and Fiorucci S. The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes. Mol Pharmacol 68 (2005) 551-558
78. Barrero M.J., and Malik S. Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. Mol Cell 24 (2006) 233-243
79. Cheung N., Chan L.C., Thompson A., Cleary M.L., and So C.W. Protein arginine-methyltransferase-dependent oncogenesis. Nature Cell Biol 9 (2007) 1208-1215
80. Lim Y., Kwon Y.H., Won N.H., Min B.H., Park I.S., Paik W.K., et al. Multimerization of expressed protein-arginine methyltransferases during the growth and differentiation of rat liver. Biochim Biophys Acta 1723 (2005) 240-247
81. Huang S., Litt M., and Felsenfeld G. Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. Genes Dev 19 (2005) 1885-1893
82. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293 (2001) 853-857
83. Fischle W., Wang Y., and Allis C.D. Binary switches and modification cassettes in histone biology and beyond. Nature 425 (2003) 475-479
84. Peterlin B.M., and Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol Cell 23 (2006) 297-305
85. Wada T., Takagi T., Yamaguchi Y., Ferdous A., Imai T., Hirose S., et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev 12 (1998) 343-356
86. Yamaguchi Y., Takagi T., Wada T., Yano K., Furuya A., Sugimoto S., et al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell 97 (1999) 41-51
87. Kim Y.K., Bourgeois C.F., Isel C., Churcher M.J., and Karn J. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation. Mol Cell Biol 22 (2002) 4622-4637
88. Saunders A., Core L.J., and Lis J.T. Breaking barriers to transcription elongation. Nat Rev 7 (2006) 557-567
89. Douziech M., Forget D., Greenblatt J., and Coulombe B. Topological localization of the carboxyl-terminal domain of RNA polymerase II in the initiation complex. J Biol Chem 274 (1999) 19868-19873
90. Morgan J.E., and Whitlock Jr. J.P. Transcription-dependent and transcription-independent nucleosome disruption induced by dioxin. Proc Natl Acad Sci USA 89 (1992) 11622-11626
91. Core L.J., and Lis J.T. Transcription regulation through promoter-proximal pausing of RNA polymerase II. Science 319 (2008) 1791-1792
92. Poland A., and Knutson J.C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22 (1982) 517-554